RIDDERPRINT  |  Digitale publicaties

Ook digitaal publiceren? De pakketten


Phase I oncology clinical trials Medical outcomes & patients’ perspectives

Adriana Johanna van der Biessen

The primary aim of phase-I oncology trials is to establish the safety profiles of new anti-cancer agents. Fit patients with cancer, without standard treatment option, can consider participation. Patients may struggle to decide whether to engage in this kind of research with unknown efficacy, benefit, and side effects, or to opt for symptom-oriented palliative care. In this thesis, both medical outcomes of phase-I clinical trials as well as research towards patients‘ perspectives are presented.

Overtuigd? Een offerte is vrijblijvend.

Vraag aan!